-- A123, DaVita, Lennar, Office Depot, Onyx, Sanderson: U.S. Equity Movers
-- Nikolaj Gammeltoft
-- 2010-07-26T20:21:18Z
-- http://www.bloomberg.com/news/2010-07-23/core-mark-morgan-stanley-porter-bancorp-u-s-equity-preview-for-july-26.html

          
          
             Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are of 4 p.m. in New York.  
 Homebuilders advanced after sales of U.S. new homes rose in
June more than forecast.  Pulte Group Inc.  (PHM US) climbed 4.7
percent to $9.07.  D.R. Horton Inc.  (DHI US) increased 3 percent
to $11.17.  Lennar Corp.  (LEN US) added 3.3 percent to $15.42.  
 Masco Corp.  (MAS US), an insulation installer, gained 4.5
percent to $11.93.  
 A123 Systems Inc.  (AONE US) rose 14 percent, the most since
Nov. 24, to $10.70. The maker of lithium batteries for plug-in
cars that sold shares in an initial public offering in September
was raised to “overweight” from “equal weight” at Barclays
Plc.  
 American International Group Inc.  (AIG US) jumped 5.3
percent to $38.70, the highest since June 21. The bailed-out
insurer, which has  units  that initiate, insure and invest in
home loans, gained after data showed that sales of new homes in
the U.S. rose more than forecast last month.  
 Alberto-Culver Co.  (ACV US) rose 5.2 percent to $30.93, the
highest price since November 2006. The maker of shampoos and
skin-care products posted earnings excluding some items of 39
cents a share, beating the average analyst estimate by 5.1
percent, according to Bloomberg data.  
 Cal-Maine Foods Inc.  (CALM US) rose 12 percent, the most
since October 2008, to $33.19. The largest U.S. egg producer
said fourth-quarter profit more than doubled to 88 cents a
share.  
 DaVita Inc.  (DVA US) climbed 7.1 percent, the most since
February 2009, to $60.86. DaVita partner  Hospira Inc.  (HSP US)
said it started a U.S. phase I clinical trial of a drug to treat
anemia in patients with kidney dysfunction. Hospira rose 1.4
percent to $58.  
 FedEx Corp.  (FDX US) rose 5.6 percent to $83.39, the
highest price since June 3. The second-largest U.S. package-
shipping company raised its earnings forecast for this quarter
and the full year on rising demand for international express
shipments.  
 FMC Technologies Inc.  (FTI US) fell 3 percent, the most
since June 7, to $61.82. The Houston-based provider of
technology for oil and natural gas fields reported revenue of
$1.01 billion in the second quarter, trailing the average
analyst estimate of $1.06 billion in a Bloomberg survey.  
 Genzyme Corp.  (GENZ US) had the second biggest gain in the
Standard & Poor’s 500 Index, adding 7.7 percent to $67.38.
GlaxoSmithKline Plc (BSK LN) recently made a “very casual”
overture to Genzyme, asking the biotechnology company to keep it
in mind if Genzyme considered selling itself, the Wall Street
Journal reported, citing an unidentified person familiar with
the matter. Sanofi-Aventis SA’s (SAN FP) takeover approach for
Genzyme was rebuffed, CNBC’s  David Faber  reported, without
saying where he got the information.  
 Biogen Idec Inc.  (BIIB US), which had gained on speculation
it was a potential takeover target, rose 8.3 percent to $57.89,
the biggest gain in the S&P 500.  
 Office Depot Inc.  (ODP US) gained 7.7 percent, the most
since May 10, to $4.73. The second-largest U.S. office-supplies
retailer is reporting earnings tomorrow. Analysts expect a loss
of 17 cents a share for the second quarter, the average of 18
estimates in a Bloomberg survey, compared with a loss of 31
cents a year ago. The retailer has posted nine consecutive
quarters of sales declines, dating back to the first quarter of
2008.  
 Onyx Pharmaceuticals Inc.  (ONXX US) surged 21 percent to
$26.04 for the biggest gain in Russell 2000 Index. The
Emeryville, California-based drugmaker said its experimental
drug carfilzomib helped about a quarter of patients with
advanced multiple myeloma whose cancer hadn’t been halted by
other therapies.  
 Sanderson Farms Inc.  (SAFM US) slid 4.1 percent to $48.67,
the lowest price since Feb. 8. The fourth-biggest U.S. chicken
producer was reduced to “underweight” from “equal weight” by
Morgan Stanley.  
 To contact the reporter on this story:
 Nikolaj Gammeltoft  in New York at 
 ngammeltoft@bloomberg.net .  
          
          


  


        